Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence
Klein, G.; Vonka, V.
Journal of the National Cancer Institute 53(6): 1645-1646
1974
ISSN/ISBN: 0027-8874 PMID: 4373574 Document Number: 73978
Document emailed within 1 workday
Related Documents
Li, Z.G. 1988: Rheumatoid arthritis associated nuclear antigen (RANA) and Epstein-Barr virus (EBV) Zhonghua Yi Xue Za Zhi 68(8): 447-449; 32Laux, G.; Adam, B.; Strobl, L.J.; Moreau-Gachelin, F. 1994: The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element EMBO Journal 13(23): 5624-5632
Schenk, B.I.; Michel, P.O.; Enders, G.; Thilo, N.; Radtke, M.; Oker, C.-Blom; Franke, D. 2007: Evaluation of a New ELISA for the Detection of Specific IgG to the Epstein-Barr Nuclear Antigen 1 (EBNA-1) Clinical Laboratory 53(3-4): 151-155
Petr, G.; Jiran, E. 1970: On the thermostability of the complement-fixing antigen of canine hepatitis virus Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-Hygienische Bakteriologie Virusforschung und Parasitologie. Originale 213(3): 325-333
Törnell, J.; Farzad, S.; Espander-Jansson, A.; Matejka, G.; Isaksson, O.; Rymo, L. 1996: Expression of Epstein-Barr nuclear antigen 2 in kidney tubule cells induce tumors in transgenic mice Oncogene 12(7): 1521-1528
Rai, J.; Basu, S.K.; Ghosh, S.N. 1977: Ultrastructure of soluble complement fixing antigen and antibody of Japanese encephalitis virus Indian Journal of Medical Research 65(2): 167-170
Brandt, W.E.; Chiewslip, D.; Harris, D.L.; Russell, P.K. 1970: Partial purification and characterization of a dengue virus soluble complement-fixing antigen Journal of Immunology 105(6): 1565-1568
Friedrich, R.E.; Bartel-Friedrich, S.; Lobeck, H.; Niedobitek, G.; Arps, H. 2000: Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma Anticancer Research 20(6d): 4909-4916
Gresíkova, M.; Sekeyová, M. 1988: A simple method of preparing a complement-fixing antigen from the virus of haemorrhagic fever with renal syndrome (Western type) Acta Virologica 32(3): 272-274
Votava, M.; Bartosová, D.; Krchnáková, A.; Crhová, K.; Kubinová, L. 1996: Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children Acta Virologica 40(2): 99-101
Naveau, S.; Delfraissy, J.F.; Poitrine, A.; Poynard, T.; Chaput, J.C. 1985: Simultaneous detection of IgM antibodies against the hepatitis a virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis Gastroenterologie Clinique et Biologique 9(2): 109-112
Suchánková, A.; Vonka, V. 1978: UV-inactivation of Epstein-Barr virus: differences in early antigen expression in two different non-productive cell lines and influence of caffeine Acta Virologica 22(5): 383-390
Takaki, K.; Harada, M.; Sairenji, T.; Hinuma, Y. 1980: Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome Journal of Immunology 125(5): 2112-2117
Roy, A.; Dey, S.; Chatterjee, R. 1994: Prevalence of serum IgG and IgM antibodies against Epstein-Barr virus capsid antigen in Indian patients with respiratory tract carcinomas Neoplasma 41(1): 29-33
Chesebro, B.; Wehrly, K.; Chesebro, K.; Portis, J. 1976: Characterization of Ia8 antigen, thy-1.2 antigen, complement receptors, and virus production in a group of murine virus-induced leukemia cell lines Journal of Immunology 117(4): 1267-1274
Chen, C-Jen.; Lin, K-Hsiang.; Lin, S-Chang.; Tsai, W-Chan.; Yen, J-Hsien.; Chang, S-Jen.; Lu, S-Nan.; Liu, H-Wen. 2005: High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies Journal of Rheumatology 32(1): 44-47
Sethi, J.; Hirshaut, Y. 1976: Complement-fixing antigen of human sarcomas Journal of the National Cancer Institute 57(3): 489-493
Larrat, S.; Morand, P.; Bas, A.; Vigne, S.; Crance, J.-M.; Boyer, V.ér.; Nicod, S.; Grossi, L.; Buisson, M.; Burmeister, W.P.; Seigneurin, J.-M.; Germi, R.ël. 2009: Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene Antiviral Therapy 14(5): 655-662
Mihalcu, F.; Ungureanu, V.; Popescu, C.; Gancevici, G. 1985: Streptolysin "0" a potentially useful antigen for complement-fixing reactions Archives Roumaines de Pathologie Experimentales et de Microbiologie 44(1): 33-36
Horácek, J. 1978: Effect of 6-mercaptopurine on cytomegalovirus replication and complement-fixing antigen formation Acta Virologica 22(2): 171